Bio-Path Holdings, Inc. (BPTH) Ownership

OTCQX: BPTHTop holders, insider trades and short interest.

BPTH ownership summary

as of October 21, 2026
Institutions
0.9%
of shares outstanding
Insiders
0.00%
of shares outstanding
Shares outstanding
50.3M
Float
50.3M
shares available to trade
Short interest
8.03%
79K shares short
Days to cover
0.92
short interest down 56.2% vs prior month
  • Institutions 0.87%
  • Insiders 0.00%
  • Other investors 99.13%

BPTH top institutional holders

17 largest
Bio-Path Holdings, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Apollon Wealth Management, LLC0.26%15K$4+14,880 (0.0%)December 31, 2024
2Geode Capital Management, LLC0.24%14K$4+2,732 (+25.1%)September 30, 2024
3Vanguard Group Inc0.23%14K$4—December 31, 2024
4Citadel Advisors Llc0.19%11K$3+10,917 (0.0%)September 30, 2024
5Tower Research Capital LLC0.06%3,371$1−362 (−9.7%)September 30, 2024
6UBS Group AG0.05%2,856$1+1,997 (+232.5%)September 30, 2024
7BlackRock Inc0.04%2,381$1—September 30, 2024
8Tradewinds Capital Management, LLC<0.01%50$0+50 (0.0%)December 31, 2024
9Morgan Stanley - Brokerage Accounts<0.01%35$0−35 (−50.0%)September 30, 2024
10Bank of America Corp<0.01%27$0−19 (−41.3%)September 30, 2024
11Group One Trading, LP<0.01%21$0—September 30, 2024
12Global Retirement Partners, LLC.<0.01%4$0—December 31, 2024
13Hanson Mcclain Inc0.00%1$0—December 31, 2024
14Qube Research & Technologies0.00%——−100 (−100.0%)September 30, 2024
15Armistice Capital, LLC0.00%——−97,000 (−100.0%)September 30, 2024
16Virtu Financial LLC0.00%——−12,325 (−100.0%)December 31, 2024
17HRT FINANCIAL LLC0.00%——−14,085 (−100.0%)September 30, 2024

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 17, 5 holders added 31K shares and 7 cut 124K.

BPTH top mutual fund and ETF holders

17 largest
Bio-Path Holdings, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard Institutional Extnd Mkt Idx Tr0.23%14K$4—December 31, 2024
2Fidelity Extended Market Index0.21%12K$4—December 31, 2024
3NT Ext Equity Mkt Idx Fd - NL0.01%550$0—December 31, 2024
4Fidelity Series Total Market Index0.01%485$0—December 31, 2024
5NT Ext Equity Mkt Idx Fd - DC - NL - T20.01%436$0−7 (−1.6%)December 31, 2024
6Northern Trust Extended Eq Market Idx0.01%305$0—December 31, 2024
7NT Ext Equity Mkt Idx Fd - L0.01%305$0—December 31, 2024
8NT Ext Eq Mkt Indx Fd DC Lend T4<0.01%73$0+73 (0.0%)December 31, 2024
9NT Ext Eq Mkt Indx Fd DC Lend T3<0.01%73$0+73 (0.0%)December 31, 2024
10NT Ext Eq Mkt Indx Fd DC Lending Tier 5<0.01%47$0—September 30, 2024
11State St US Ttl Mkt Indx SL Cl I<0.01%45$0—January 31, 2025
12Northern Trust Wilshire 5000<0.01%13$0—December 31, 2024
13BNYM Mellon SL Market Completion UC1<0.01%12$0—December 31, 2024
14State St US Extended Mkt Indx NL Cl C<0.01%9$0—January 31, 2025
15SSgA U.S. Total Market Index Strategy<0.01%4$0+1 (+33.3%)June 30, 2024
16BNYM Mellon NSL Mkt Completion Fund Inst0.00%2$0—December 31, 2024
17Blackstone Alternative Multi-Strategy I0.00%1$0—September 30, 2024

Funds report holdings monthly or quarterly; dates differ by fund.

BPTH insider transactions

latest 4
Bio-Path Holdings, Inc. insider transactions
DateNameTransactionPriceSharesValue
2019-01-18Armistice Capital Master FundSell$2.6664,457$171,456
2015-07-13Michael J GarrisonBuy$1.227,343$8,958
2015-07-09Michael J GarrisonBuy$1.178,724$10,207
2015-07-08Michael J GarrisonBuy$1.1960,000$71,400

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

BPTH shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns BPTH

Institutional investors own 0.9% of Bio-Path's shares and insiders 0.00%. The largest holder is Apollon Wealth Management, LLC with 0.26% of the shares (15K), as of December 31, 2024. Among the top 17 institutions, 5 added shares and 7 reduced their stake in the latest filings. Short interest is 8.03% of the float, or 0.92 days of average trading volume. The share count rose 745.3% since 2013.

Related: BPTH analyst forecast, BPTH key metrics. See the BPTH stock overview for the latest quote and news.

BPTH ownership FAQ

Who owns the most Bio-Path stock?

The largest shareholders of Bio-Path are Apollon Wealth Management, LLC (0.26%), Geode Capital Management, LLC (0.24%), Vanguard Group Inc (0.23%), Citadel Advisors Llc (0.19%), Tower Research Capital LLC (0.06%).

What percentage of Bio-Path is owned by institutions?

Institutions hold 0.9% of Bio-Path's shares outstanding; insiders hold 0.00%.

Which funds own Bio-Path?

The largest fund holders of Bio-Path are Vanguard Institutional Extnd Mkt Idx Tr (0.23%), Fidelity Extended Market Index (0.21%), NT Ext Equity Mkt Idx Fd - NL (0.01%), Fidelity Series Total Market Index (0.01%), NT Ext Equity Mkt Idx Fd - DC - NL - T2 (0.01%).

What is Bio-Path's short interest?

79K shares of Bio-Path were sold short, 8.03% of the float; at the average daily volume it would take 0.92 days to cover.

Are insiders buying or selling Bio-Path?

Of the latest 4 reported insider transactions in Bio-Path (since July 8, 2015), 3 were purchases and 1 were sales.

How many shares of Bio-Path are outstanding?

Bio-Path has 50.3M shares outstanding, of which 50.3M are in the public float.

Biotechnology: ownership